1.
Nat Biotechnol
; 24(12): 1529-31, 2006 Dec.
Article
in English
| MEDLINE
| ID: mdl-17160057
ABSTRACT
Patent and regulatory hurdles combined with low returns on investment are stifling antibiotic R&D in the pharmaceutical industry.